All In MedTech

FDA Clearance Tracker · P970015-S022

LT-CAGE PEEK LUMBAR TAPERED FUSION DEVICE

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Sep 10, 2003 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Sep 10, 2003

Approved

Time to decision

315 days

Received Oct 30, 2002. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class II

The decision

FDA number
P970015-S022
Device name
LT-CAGE PEEK LUMBAR TAPERED FUSION DEVICE
Applicant
Sofamor Danek
Applicant location
Memphis, TN
Received
Oct 30, 2002
Decided
Sep 10, 2003
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P970015

Device type

Device class
Class II
Regulation
21 CFR 888.3080

Every decision under product code MAX

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE LT-CAGE PEEK LUMBER TAPERED FUSION DEVICE, WHICH IS MANUFACTURED FROM POLYETHERETHERKE-TONE, WITH THE TRADE NAME OF PEEK-OPTIMA LT1. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME LT-CAGE PEEK LUMBAR TAPERED FUSION DEVICE AND IS INDICATED FOR SPINAL FUSION PROCEDURES IN SKELETALLY MATURE PATIENTS WITH DEGERNERATIVE DISC DISEASE (DDD) AT ONE LEVEL FROM L2-S1. DDD IS DEFINED AS DISCOGENIC BACK PAIN WITH DEGENERATION OF THE DISC CONFIRMED BY PATIENT HISTORY AND RADIOGRAPHIC STUDIES. THESE DDD PATIENTS ALSO HAVE UP TO GRADE I SPONDYLOLISTHESIS OR RETROLISTHESIS AT THE INVOLVED LEVEL. LT-CAGE PEEK IMPLANTS ARE TO BE USED WITH AUTOGENOUS BONE GRAFT AND IMPLANTED VIA A LAPAROSCOPIC OR AN OPEN ANTERIOR APPROACH. PATIENTS RECEIVING THE LT-CAGE PEEK LUMBAR TAPERED FUSION DEVICE SHOULD HAVE AT LEAST SIX MONTHS OF NON-OPERATIVE TREATMENT PRIOR TREATMENT WITH THE LT-CAGE PEEK DEVICE.

Source documents

Other decisions for Sofamor Danek

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.